Results 11 to 20 of about 81,794 (294)
DIFFUSE SCLEROSING PNEUMOCYTOMA (SCLEROSING HAEMANGIOMA)
Туберкулез и болезни лёгких, 2017 Sclerosing pneumocytoma is a rare tumor. Most frequently it occurs in women at the age from 30 to 50 years old. Prevalently sclerosing pneumocytoma is a tumor with a single localization at the periphery of the lung.
A. A. Sadovnikov +3 more
doaj +3 more sources
Hepatology, EarlyView., 2022 IL‐31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases Abstract Background and Aims Pruritus is associated with multiple liver diseases, particularly those with cholestasis, but the mechanism remains incompletely understood.
Jun Xu +20 more
wiley +1 more source
Health disparities in chronic liver disease
Hepatology, EarlyView., 2022 Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian +3 more
wiley +1 more source
Hepatology, EarlyView., 2022 In this study of the gut mucosal microbiota in primary sclerosing cholangitis (PSC), we found consistent microbiota features associated with PSC and recurrent PSC, PSC with inflammatory bowel disease and a persistent gut dysbiosis after liver transplantation Abstract Background and Aims Several characteristic features of the fecal microbiota have been ...
Mikal Jacob Hole +12 more
wiley +1 more source
Clinical and Image Characteristics of IgG4-Related Sclerosing Cholecystitis
Diagnostics, 2021 Since autoimmune pancreatitis (AIP) was established as a new disease entity, sclerosing change with abundant immunoglobulin-4 (IgG4)-positive plasma cells, storiform fibrosis, and obliterative phlebitis are main pathological features in IgG4-related ...
Masaki Kuwatani, Naoya Sakamoto
doaj +1 more source
Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases [PDF]
, 2020 In the past ten years, our understanding of the importance of bile acids has expanded from fat absorption and glucose/lipid/energy homeostasis into potential therapeutic targets for amelioration of chronic cholestatic liver diseases.
Alpini, Gianfranco +4 more
core +1 more source
Current Opinion in Gastroenterology, 1995 Primary sclerosing cholangitis is a chronic cholestatic liver disease of unknown etiology. Immunogenetic factors are considered important in its pathogenesis. The genetic susceptibility to primary sclerosing cholangitis is associated, in part, with the HLA HLA-DRB1, DQA1, DQB1 haplotype.
Martins, E, Chapman, R
openaire +6 more sources
Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma [PDF]
, 2016 The diagnosis of primary sclerosing cholangitis (PSC) is difficult due to the lack of sensitive and specific biomarkers, as is the early diagnosis of cholangiocarcinoma (CC), a complication of PSC.
Alpini, Gianfranco +17 more
core +2 more sources
Sclerosing mesenteritis: An unusual cause of intestinal obstruction
International Journal of Advanced Medical and Health Research, 2015 Mesenteric panniculitis is a rare, benign, and complex disorder. This is a chronic inflammatory process of mesenteric adipose tissue of unknown etiology. Based on the histopathological spectrum seen i.e., chronic inflammation, fat necrosis, and fibrosis,
Parasa Gayathri Devi +3 more
doaj +1 more source
Epidemiology of Autoimmune Liver Disease
The Korean Journal of Gastroenterology, 2023 Autoimmune liver disease is an important immune-mediated pathologic entity involving the liver and intrahepatic bile duct, including autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis.
Nae-Yun Heo
doaj +1 more source